Founder in Residence - Fibrosis Therapeutics - Remote

Overview

Deep Science Ventures is creating a future in which both humans and the planet can thrive. We use our unique venture creation process to create, spin-out and invest into science companies, combining available scientific knowledge and founder-type scientists into high-impact ventures.

In Short

• Join DSV’s venture creation programme as a Founder-in-Residence.
• Work on fibrosis drug development focusing on protein engineering and myeloid reprogramming.
• Refine therapeutic approaches and clinical positioning.
• Prepare for investment decision committees and recruit team members.
• Receive pre-seed investment and spin out the company.
• Address unmet medical needs in fibrotic diseases.
• Focus on creating impactful new medicines.
• Explore multiple strategies for drug development.
• Lead efforts to transform the vision into reality.
• Majority stake ownership post-spinout.

Requirements

• Deep technical and commercial domain expertise.
• Entrepreneurial mindset.
• Experience in protein engineering or myeloid reprogramming.
• Ability to solve urgent unmet challenges.
• Familiarity with clinical trials and drug development processes.
• Strong understanding of IP strategy and market differentiation.
• Experience in fundraising and team recruitment.
• Ability to work collaboratively with diverse teams.
• Strong communication and leadership skills.
• Passion for advancing medical science.

Benefits

• Opportunity to lead in a high-impact venture.
• Support from experienced partners in the field.
• Ownership stake in the new company.
• Access to resources and networks of DSV and GI.
• Potential for significant financial rewards.
• Work on groundbreaking therapeutics.
• Contribute to addressing global health challenges.
• Collaborative and innovative work environment.
• Professional growth and development opportunities.
• Engagement in a mission-driven organization.